本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Candel Therapeutics, Inc.

5.40
+0.09001.69%
盤後5.400.00000.00%19:41 EDT
成交量:57.42萬
成交額:311.49萬
市值:2.96億
市盈率:-10.34
高:5.51
開:5.39
低:5.33
收:5.31
52周最高:14.60
52周最低:3.79
股本:5,489.51萬
流通股本:4,547.85萬
量比:0.88
換手率:1.26%
股息:- -
股息率:- -
每股收益(TTM):-0.5221
每股收益(LYR):-1.7420
淨資產收益率:-55.18%
總資產收益率:-33.39%
市淨率:3.29
市盈率(LYR):-3.10

資料載入中...

2025/03/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/13

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/13

重要事件披露

Form 8-K - Current report
2025/03/13

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/25

重要事件披露

Form 8-K - Current report
2025/01/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/13

重要事件披露

Form 8-K - Current report
2025/01/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/17

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/12/13

重要事件披露

Form 8-K - Current report
2024/12/11

重要事件披露

Form 8-K - Current report
2024/11/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities